Level Four Advisory Services, LLC Neurocrine Biosciences Inc Transaction History

Level Four Advisory Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$130.4 - $143.74 $16,691 - $18,398	128 Added 2.59%	5,070 $699,000
Q4 2023 Feb 08, 2024	BUY	$106.07 - $132.76 $524,197 - $656,099	4,942 New	4,942 $651,000
Q4 2022 Feb 13, 2023	SELL	$106.72 - $127.06 $206,289 - $245,606	-1,933 Reduced 25.09%	5,772 $689,000
Q3 2022 Nov 07, 2022	SELL	$92.03 - $107.81 $438,154 - $513,283	-4,761 Reduced 38.19%	7,705 $818,000
Q2 2022 Aug 08, 2022	BUY	$75.79 - $100.07 $564,787 - $745,721	7,452 Added 148.62%	12,466 $1.22 Million
Q1 2022 May 10, 2022	BUY	$72.45 - $94.81 $363,264 - $475,377	5,014 New	5,014 $470,000

624

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.8B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Level Four Advisory Services, LLC with notifications on news.